Source link : https://newshealth.biz/health-news/eu-clears-path-for-biosimilars-in-diabetes-bone-health/
The EMA’s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, lower-cost biologics across the European Union. Medscape News Europe Source link : https://www.medscape.com/viewarticle/eu-clears-path-biosimilars-diabetes-bone-health-2025a1000vxz?src=rss Author : Publish date : 2025-11-17 15:14:00 Copyright for syndicated content belongs to the linked Source.
The post EU Clears Path for Biosimilars in Diabetes & Bone Health first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-17 15:14:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8